Friday, November 13, 2026

83% of Companies Worldwide Struggle with AI Infrastructure as Cloud Reliance Surges

83% of organizations globally report their teams cannot handle AI workloads internally, driving mass migration to cloud platforms. 72% now outsource AI infrastructure to third parties, while 97% view cloud as essential for scaling. The shift reflects widespread talent shortages and infrastructure complexity across international markets.

83% of Companies Worldwide Struggle with AI Infrastructure as Cloud Reliance Surges
Image generated by AI for illustrative purposes. Not actual footage or photography from the reported events.

83% of organizations worldwide say internal teams struggle with AI workloads, according to enterprise adoption data spanning global markets. The gap between AI ambitions and operational capacity affects companies across North America, Europe, and Asia-Pacific equally.

97% of organizations now consider cloud infrastructure essential for AI scaling. More than half cite cloud as their fastest production path, avoiding months-long on-premises deployments that require scarce engineering talent.

Complexity drives outsourcing across borders. 65% of companies describe AI environments as too complex for internal management. 72% rely on third-party providers to build and manage infrastructure—a trend consistent from Silicon Valley to Singapore.

Major cloud platforms compete globally for AI market share. AWS, Google Cloud, Microsoft Azure, and newcomers like Akamai's Inference Cloud offer services from data centers spanning continents. These platforms handle deployment, scaling, and optimization tasks that internal teams cannot staff.

Economic pressure transcends regions. Companies worldwide face costs for GPU clusters, storage, networking, and specialized talent—scarce in every major tech hub. Cloud services convert capital expenses into predictable operational costs.

The expertise gap crosses borders. Organizations in London, Tokyo, and São Paulo report identical challenges: rapid AI framework evolution, diverse hardware needs, legacy system integration, and engineer shortages. Setup cycles stretch months before first production deployment.

Third-party providers offer immediate access to pre-configured environments maintained across AI frameworks. For companies in markets with acute talent shortages—including emerging tech hubs—cloud adoption becomes necessity rather than choice.

Quarterly revenue from global cloud providers will test whether this infrastructure shift accelerates through 2027 across international markets.


Sources:
1 Globe Newswire, "Olympians Inspire Expands School Assembly and Leadership Workshop Programming Featuring Elite Athlet" (March 23, 2026)
2 Yahoo Finance, "Asian shares decline as hopes dim for resolution in Iran after Trump's latest comments" (March 23, 2026)

In this story · Knowledge Files

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,577 source documents archived
Query this data → isubstrate.com